- Home
- MNDR vs SBFM Comparison
MNDR vs SBFM Comparison
Compare MNDR & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDR
- SBFM
- Stock Information
- Founded
- MNDR 2016
- SBFM 2006
- Country
- MNDR Singapore
- SBFM United States
- Employees
- MNDR N/A
- SBFM N/A
- Industry
- MNDR
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- MNDR
- SBFM Health Care
- Exchange
- MNDR Nasdaq
- SBFM Nasdaq
- Market Cap
- MNDR 6.8M
- SBFM 6.5M
- IPO Year
- MNDR 2024
- SBFM N/A
- Fundamental
- Price
- MNDR $1.09
- SBFM $1.49
- Analyst Decision
- MNDR
- SBFM Strong Buy
- Analyst Count
- MNDR 0
- SBFM 1
- Target Price
- MNDR N/A
- SBFM $15.00
- AVG Volume (30 Days)
- MNDR 400.3K
- SBFM 54.6K
- Earning Date
- MNDR 06-16-2025
- SBFM 08-12-2025
- Dividend Yield
- MNDR N/A
- SBFM N/A
- EPS Growth
- MNDR N/A
- SBFM N/A
- EPS
- MNDR N/A
- SBFM N/A
- Revenue
- MNDR $11,600,567.00
- SBFM $36,341,741.00
- Revenue This Year
- MNDR $188,831.77
- SBFM $32.20
- Revenue Next Year
- MNDR $76.44
- SBFM $32.74
- P/E Ratio
- MNDR N/A
- SBFM N/A
- Revenue Growth
- MNDR 0.61
- SBFM 19.22
- 52 Week Low
- MNDR $0.84
- SBFM $1.17
- 52 Week High
- MNDR $8.00
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- MNDR N/A
- SBFM 51.16
- Support Level
- MNDR N/A
- SBFM $1.35
- Resistance Level
- MNDR N/A
- SBFM $1.52
- Average True Range (ATR)
- MNDR 0.00
- SBFM 0.08
- MACD
- MNDR 0.00
- SBFM 0.01
- Stochastic Oscillator
- MNDR 0.00
- SBFM 66.30
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.